Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	46.09	-13.03	-24.17
Graham Fair Price	41.42	0.27	0.19
PEG	-71.45	-0.02	0.06
Price/Book	1.33	-6.58	-6.67
Price/Cash Flow	-51.61	19.59	40.47
Prices/Earnings	50.67	-1.57	-3.19
Price/Sales	-50.67	1.96	3.97
Price/FCF	-51.61	19.59	40.47
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-75.60	< 0.005	0.02
Operating Margin	0.00	-0.24	-0.24
ROA	-100.00	-0.07	-0.03
ROE	0.52	1.05	100.00
ROIC	-0.10	-0.20	-93.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.03	-0.48	-94.50
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.66	-1.00	51.61
EPS QOQ	0.58	-1.00	72.77
FCF QOQ	-0.82	1.04	26.64
Revenue QOQ	-0.65	1.00	53.77
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	23.22	11.44	-50.76
Days Sales Outstanding (DSO)	538.68	269.34	-50.00
Inventory Turnover	3.88	7.87	103.08
Debt/Capitalization	1.26	1.25	-0.65
Quick Ratio	0.78	0.78	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-0.06	-0.06	0.00
Cash	0.13	0.13	0.00
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	< 0.005	0.02	103.89
Revenue	0.09	0.19	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.95	0.95	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.65	-3.75	43.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating